The utility of sputum eosinophils and exhaled nitric oxide for monitoring asthma control with special attention to childhood asthma

Allergologia et Immunopathologia

Volumn 38, Issue 1, 2010, Pages 41-46

  Garcia Marcos, L ^a,b   Brand, P L ^c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Princess Amalia Children's Clinic   (Netherlands)

Author keywords

Asthma treatment; Children; Induced sputum

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; DITHIOTHREITOL; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE PROPIONATE; MONTELUKAST; NITRIC OXIDE; PLACEBO; PREDNISOLONE; PREDNISONE; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ASTHMA; CHILD; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DOSE COMPARISON; EOSINOPHIL COUNT; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; PATIENT ASSESSMENT; PATIENT MONITORING; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; REVIEW; SAMPLING; SEVERE PERSISTENT ASTHMA; SINGLE DRUG DOSE; SPUTUM ANALYSIS; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BREATH TESTS; CELL COUNT; CHILD; DITHIOTHREITOL; DOUBLE-BLIND METHOD; DRUG MONITORING; EOSINOPHILIA; HUMANS; LEUKOTRIENE ANTAGONISTS; NITRIC OXIDE; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SALINE SOLUTION, HYPERTONIC; SPECIMEN HANDLING; SPUTUM;

EID: 77949323133     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2009.10.006     Document Type: Review

References (50)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention (2005), NIH Publication No 02-3659
2. Gibson P.G., Girgis-Gabardo A., Morris M.M., Mattoli S., Kay J.M., Dolovich J., et al. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 44 (1989) 693-699
3. Pin I., Gibson P.G., Kolendowicz R., Girgis-Gabardo A., Denburg J.A., Hargreave F.E., et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47 (1992) 25-29
4. Hargreave F.E., Popov T., Kidney J., and Dolovich J. Sputum measurements to assess airway inflammation in asthma. Allergy 48 (1993) 81-83
5. Pavord I.D., Pizzichini M.M., Pizzichini E., and Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax 52 (1997) 498-501
6. Popov T., Gottschalk R., Kolendowicz R., Dolovich J., Powers P., and Hargreave FE. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy 24 (1994) 778-783
7. Wooten O.J., and Dulfano MJ. Improved homogenization techniques for sputum cytology counts. Ann Allergy 41 (1978) 150-154
8. Daviskas E., Anderson S.D., Gonda I., Eberl S., Meikle S., Seale J.P., et al. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur Respir J 9 (1996) 725-732
9. Gibson P.G., Henry R.L., and Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 16 (2000) 1008-1015
10. Gershman N.H., Wong H.H., Liu J.T., Mahlmeister M.J., and Fahy JV. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur Respir J 9 (1996) 2448-2453
11. Kips J.C., Peleman R.A., and Pauwels RA. Methods of examining induced sputum: do differences matter?. Eur Respir J 11 (1998) 529-533
12. Saraiva-Romanholo B.M., Barnabe V., Carvalho A.L., Martins M.A., Saldiva P.H., and Nunes MP. Comparison of three methods for differential cell count in induced sputum. Chest 124 (2003) 1060-1066
13. Gibson P.G., Simpson J.L., and Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119 (2001) 1329-1336
14. Brightling CE. Clinical applications of induced sputum. Chest 129 (2006) 1344-1348
15. Little S.A., Chalmers G.W., MacLeod K.J., McSharry C., and Thomson NC. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 55 (2000) 232-234
16. Pavord I.D., Brightling C.E., Woltmann G., and Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 353 (1999) 2213-2214
17. Green R.H., Brightling C.E., Woltmann G., Parker D., Wardlaw A.J., and Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57 (2002) 875-879
18. Basyigit I., Yildiz F., Ozkara S.K., Boyaci H., and Ilgazli A. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Mediators Inflamm 13 (2004) 285-291
19. Sigurs N., Bjarnason R., Sigurbergsson F., and Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161 (2000) 1501-1507
20. Pizzichini E., Pizzichini M.M., Efthimiadis A., Evans S., Morris M.M., Squillace D., et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 154 (1996) 308-317
21. Hunter C.J., Brightling C.E., Woltmann G., Wardlaw A.J., and Pavord ID. A comparison of the validity of different diagnostic tests in adults with asthma. Chest 121 (2002) 1051-1057
22. Bartoli M.L., Bacci E., Carnevali S., Cianchetti S., Dente F.L., Di Franco A., et al. Clinical assessment of asthma severity partially corresponds to sputum eosinophilic airway inflammation. Respir Med 98 (2004) 184-193
23. Park J.W., Whang Y.W., Kim C.W., Park Y.B., and Hong CS. Eosinophil count and eosinophil cationic protein concentration of induced sputum in the diagnosis and assessment of airway inflammation in bronchial asthma. Allergy Asthma Proc 19 (1998) 61-67
24. Fujimoto K., Yamaguchi S., Urushibata K., Koizumi T., and Kubo K. Sputum eosinophilia and bronchial responsiveness in patients with chronic non-productive cough responsive to anti-asthma therapy. Respirology 8 (2003) 168-174
25. Pizzichini E., Pizzichini M.M., Efthimiadis A., Dolovich J., and Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 99 (1997) 539-544
26. Bacci E., Cianchetti S., Ruocco L., Bartoli M.L., Carnevali S., Dente F.L., et al. Comparison between eosinophilic markers in induced sputum and blood in asthmatic patients. Clin Exp Allergy 28 (1998) 1237-1243
27. Chan-Yeung M., Obata H., Dittrick M., Chan H., and Abboud R. Airway inflammation, exhaled nitric oxide, and severity of asthma in patients with western red cedar asthma. Am J Respir Crit Care Med 159 (1999) 1434-1438
28. Jatakanon A., Lim S., and Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 161 (2000) 64-72
29. Louis R., Lau L.C., Bron A.O., Roldaan A.C., Radermecker M., and Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161 (2000) 9-16
30. Woodruff P.G., Khashayar R., Lazarus S.C., Janson S., Avila P., Boushey H.A., et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 108 (2001) 753-758
31. Berlyne G.S., Parameswaran K., Kamada D., Efthimiadis A., and Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 106 (2000) 638-644
32. Jones S.L., Herbison P., Cowan J.O., Flannery E.M., Hancox R.J., McLachlan C.R., et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 20 (2002) 601-608
33. Covar R.A., Spahn J.D., Martin R.J., Silkoff P.E., Sundstrom D.A., Murphy J., et al. Safety and application of induced sputum analysis in childhood asthma. J Allergy Clin Immunol 114 (2004) 575-582
34. Boulet L.P., Boulet V., and Milot J. How should we quantify asthma control? A proposal. Chest 122 (2002) 2217-2223
35. Claman D.M., Boushey H.A., Liu J., Wong H., and Fahy JV. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 94 (1994) 861-869
36. Jatakanon A., Lim S., Chung K.F., and Barnes PJ. An inhaled steroid improves markers of airway inflammation in patients with mild asthma. Eur Respir J 12 (1998) 1084-1088
37. Jatakanon A., Kharitonov S., Lim S., and Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 54 (1999) 108-114
38. Aldridge R.E., Hancox R.J., Cowant J.O., Frampton C.M., Town G.I., and Taylor DR. Eosinophils and eosinophilic cationic protein in induced sputum and blood: effects of budesonide and terbutaline treatment. Ann Allergy Asthma Immunol 89 (2002) 492-497
39. van Rensen E.L., Straathof K.C., Veselic-Charvat M.A., Zwinderman A.H., Bel E.H., and Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 54 (1999) 403-408
40. Pizzichini E., Leff J.A., Reiss T.F., Hendeles L., Boulet L.P., Wei L.X., et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 14 (1999) 12-18
41. Dente F.L., Bancalari L., Bacci E., Bartoli M.L., Carnevali S., Cianchetti S., et al. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Thorax 54 (1999) 622-624
42. Bacci E., Di Franco A., Bartoli M.L., Carnevali S., Cianchetti S., Dente F.L., et al. Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma. Eur Respir J 20 (2002) 66-72
43. Aizawa H., Iwanaga T., Inoue H., Takata S., Matsumoto K., Takahashi N., et al. Once-daily theophylline reduces serum eosinophil cationic protein and eosinophil levels in induced sputum of asthmatics. Int Arch Allergy Immunol 121 (2000) 123-128
44. Giannini D., Di Franco A., Cianchetti S., Bacci E., Dente F.L., Vagaggini B., et al. Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients. Clin Exp Allergy 30 (2000) 1777-1784
45. Deykin A., Lazarus S.C., Fahy J.V., Wechsler M.E., Boushey H.A., Chinchilli V.M., et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 115 (2005) 720-727
46. Zacharasiewicz A., Wilson N., Lex C., Erin E.M., Li A.M., Hansel T., et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 171 (2005) 1077-1082
47. Li A.M., Tsang T.W., Lam H.S., Sung R.Y., and Chang AB. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma. Respirology 13 (2008) 400-407
48. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002) 1715-1721
49. Jayaram L., Pizzichini M.M., Cook R.J., Boulet L.P., Lemiere C., Pizzichini E., et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27 (2006) 483-494
50. Li A.M., Tsang T.W., Chan D.F., Lam H.S., So H.K., Sung R.Y., et al. Cough frequency in children with mild asthma correlates with sputum neutrophil count. Thorax 61 (2006) 747-750